A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Cited by (999)

Items 901–999 of 999

1. GOWDL: gene ontology-driven wide and deep learning model for cell typing of scRNA-seq data
   Antonino Fiannaca, Massimo La Rosa, Laura La Paglia, Salvatore Gaglio, Alfonso M. Urso · 2023 · Briefings in Bioinformatics
2. Cancer Stemness Online: A Resource for Investigating Cancer Stemness and Associations with Immune Response
   Weiwei Zhou, Minghai Su, Tiantongfei Jiang, Yunjin Xie, Jingyi Shi, Yingying Ma, Kang Xu, Gang Xu, Yongsheng Li, Juan Xu · 2024 · Genomics Proteomics & Bioinformatics
3. Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer
   Hye-Eun Byeon, Seokjin Haam, Jae Ho Han, Hyun Woo Lee, Young Wha Koh · 2022 · Cancers
4. Identifying phenotype-associated subpopulations through LP_SGL
   Juntao Li, Hongmei Zhang, Bingyu Mu, Hongliang Zuo, Kanglei Zhou · 2023 · Briefings in Bioinformatics
5. Functional analysis of recurrent CDC20 promoter variants in human melanoma
   Paula M. Godoy, Abimbola Oyedeji, Jacqueline L. Mudd, Vasilios Aris Morikis, Anna P. Zarov, Gregory D. Longmore, Ryan Courtney Fields, Charles K. Kaufman · 2023 · Communications Biology
6. Multi-omics and tumor immune microenvironment characterization of a prognostic model based on aging-related genes in melanoma
   Zhenghao He · 2024 · American Journal of Cancer Research
7. Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance
   Qingshan Chen, Fenglin Gao, Junwan Wu, Kai-Ming Zhang, Tian Du, Yuhong Chen, Ruizhao Cai, Dechang Zhao, Rong Deng, Jun Tang · 2024 · Clinical and Translational Medicine
8. scParser: sparse representation learning for scalable single-cell RNA sequencing data analysis
   Kai Zhao, Hon‐Cheong So, Zhixiang Lin · 2024 · Genome biology
9. Cellular censuses to guide cancer care
   Michael S. Eisenstein · 2019 · Nature
10. CXCR3: Here to stay to enhance cancer immunotherapy?
    Meri Rogava, Benjamin Izar · 2019 · EBioMedicine
11. Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma
    Otto Luiz Dutra Cerqueira, Fernanda Antunes, Nadine Gimenez de Assis, Elaine Cristina Cardoso, Maria Alejandra Clavijo-Salomon, Ana Carolina Martins Domingues, Nayara Gusmão Tessarollo, Bryan Eric Strauss · 2022 · Frontiers in Molecular Biosciences
12. Bioinformatics Analysis Identified Five Widely Expressed Genes Associated with Prognosis in Sarcoma
    Bizhi Tu, Yaya Jia, Jun Qian · 2022 · International Journal of General Medicine
13. Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development
    Paul R. Barber, Rami Mustapha, Fabian Flores‐Borja, Giovanna Alfano, Kenrick Ng, Gregory E. Weitsman, Luigi Dolcetti, Ali Abdulnabi Suwaidan, Felix Wong, Jose Miguel Vicencio et al. · 2022 · eLife
14. Progress in Understanding Complexity and Determinants of Immune-Related Prognostic Subsets in Primary Melanoma
    Andrea Anichini · 2019 · Cancer Research
15. Single-cell regulatory network inference and clustering from high-dimensional sequencing data
    Aristidis G. Vrahatis, Georgios Ν. Dimitrakopoulos, Sotiris K. Tasoulis, Spiros V. Georgakopoulos, Vassilis P. Plagianakos · 2019 · IEEE International Conference on Big Data (BigData)
16. Single Cell Sequencing: A New Dimension in Cancer Diagnosis and Treatment
    Fengying Wu, Jue Fan, Jingwen Fang, Priya S. Dalvi, Margarete Odenthal, Nan Fang · 2020 · Advances in experimental medicine and biology
17. Gene biomarker prediction in glioma by integrating scRNA-seq data and gene regulatory network
    Guimin Qin, Yuying Ma, Yuhan Yang, Yu Yin, Xiyang Liu, Liming Wang · 2021 · BMC Medical Genomics
18. An elastic-net logistic regression approach to generate classifiers and gene signatures for types of immune cells and T helper cell subsets
    Arezo Torang, Paraag Gupta, David J. Klinke · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
19. UniPath: A uniform approach for pathway and gene-set based analysis of heterogeneity in single-cell epigenome and transcriptome profiles
    Smriti Chawla, Sudhagar Samydurai, Say Li Kong, Zhenxun Wang, Wai Leong Tam, Debarka Sengupta, Vibhor Kumar · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
20. STIG: Generation and simulated sequencing of synthetic T cell receptor repertoires
    Mark G. Woodcock, Dante S. Bortone, Benjamin Garrett Vincent · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
21. Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade
    Arnav Mehta, Marijana Ručević, Emmett Sprecher, Milan Parikh, Jiajia Chen, Dennie Tompers Frederick, Elliot C. Woods, Lynn Bi, David Lieb, Lina Hultin‐Rosenberg et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
22. Tumor cell p38 inhibition to overcome immunotherapy resistance
    Jason J. Luke, Rebekah Dadey, Ryan C. Augustin, Sarah Newman, Krishna Beer Singh, Rose Doerfler, Sarah Behr, Patrice Lee, Brian Robert Isett, Christopher Deitrick et al. · 2023 · Research Square
23. Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanoma
    Tuulia Vallius, Yingxiao Shi, Edward Novikov, Shishir Mani Pant, Roxanne J. Pelletier, Yu‐An Chen, Juliann B. Tefft, Ajit J. Nirmal, Zoltan Maliga, Guihong Wan et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
24. Phagocytic clearance of targeted cells with a synthetic ligand
    Yuki Yamato, Jun Suzuki · 2025 · Nature Biomedical Engineering
25. Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update
    Jianan Lu, Jiangnan Yu, Tao Xu, Yina Li, Shuxian Chen, Qian Zhou, Lei Wang · 2025 · Cancer Drug Resistance
26. Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapy
    Martin Barainka, Angelina Zheleva, Ángela Pérez-Cervera, Helena Villanueva, Daniel Meraviglia-Crivelli, Beatriz Moreno, Fernando Pastor · 2026 · iScience
27. Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation
    Hyo-Jung Lee, Eunho Cho, Kwon‐Ho Song, Tae Woo Kim · 2026 · Immune Network
28. Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological Malignancies
    Sevgi Gezici · 2023 · Elsevier eBooks
29. Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy
    Zhihao Qi, Yao Cheng, Kaizhen Wang, Shi Cai, Xiang Ni, Tianyu Wang, Kuojun Zhang, Sheng Jiang, Yibei Xiao, Xiangyu Zhang · 2025 · Journal of Medicinal Chemistry
30. Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder cancer
    Yingjie Li, Wenjie Yang, Hualin Chen, Zhaoheng Jin, Jie Dong, Lin Ma, Zhigang Ji · 2025 · International Immunopharmacology
31. Combining single-cell and bulk RNA sequencing to identify CAF-related signature for prognostic prediction and treatment response in patients with melanoma
    Jing Wang, Ying Song, Zifu Li, Tianxiang Gao, Wei Shen, Zijian Kang, Chong‐Rui Xu · 2025 · Scientific Reports
32. Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancer
    Hafiza Bushra Manzoor, Melisa Acun, Hamed Yasavoli‐Sharahi, Chantal Matar, Arvind Singh Mer, Benjamin K. Tsang, Meshach Asare-Werehene · 2025 · Scientific Reports
33. CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling
    Robin Minati, Maxime Cahuzac, Julie Perrault, Véronique Lullier, Anca Apavaloaei, Éric Bonneil, Mathieu Courcelles, Joël Lanoix, Eralda Kina, Claude Perreault et al. · 2025 · Cell Reports
34. Targeted protein degradation: species, diseases and efficient utilization
    Tian Yue, Jian He, Jun Hou · 2025 · Journal of Translational Medicine
35. Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer
    Ying Chen Guo, Na Yang, Gang Li, Xiurong Yin, Lixia Dong · 2022 · Journal of Immunology Research
36. PD-L1 Expression and Overall Survival in Asian and Western Patients with Gastric Cancer
    Sun Young Rha, Geoffrey Yuyat Ku, Hyo Song Kim, Hyun Cheol Chung, Fatemeh Ghazanfari Amlashi, Dipen Maheshbhai Maru, Carly Fein, Laura H. Tang, Wei Zhou, Ting Wu et al. · 2022 · Future Oncology
37. SMG7-AS1 as a prognostic biomarker and predictor of immunotherapy responses for skin cutaneous melanoma
    Xuezheng Xu, Yikun Ju, Xueheng Zhao, Pu Yang, Fang Zhu, Bairong Fang · 2023 · Genomics
38. Head-to-Head Comparison of CCN4, DNMT3A, PTPN11, and SPARC as Suppressors of Anti-tumor Immunity
    Anika Pirkey, Wentao Deng, Danielle Norman, Atefeh P. Razazan, David J. Klinke · 2023 · Cellular and Molecular Bioengineering
39. Reusability report: Leveraging supervised learning to uncover phenotype-relevant biology from single-cell RNA sequencing data
    Yingying Cao, Tiangen Chang, Sahil Sahni, Eytan Ruppin · 2024 · Nature Machine Intelligence
40. Visualizing scRNA-Seq data at population scale with GloScope
    Hao Wang, William Torous, Boying Gong, Elizabeth A. Purdom · 2024 · Genome biology
41. DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance
    Kathleen Conway, Sharon N. Edmiston, Amanda M. Vondras, Allison Reiner, David L. Corcoran, Ronglai Shen, Eloise Parrish, Honglin Hao, Lan Lin, Jessica M. Kenney et al. · 2024 · JCO Precision Oncology
42. Identifying cell types by lasso-constraint regularized Gaussian graphical model based on weighted distance penalty
    Wei Zhang, Yaxin Xu, Xiaoying Zheng, Juan Shen, Yuanyuan Li · 2024 · Briefings in Bioinformatics
43. Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies
    Yi Du, Yang Yang, Bohao Zheng, Qian Zhang, Shengtao Zhou, Linjie Zhao · 2025 · Oncogene
44. A novel molecular classification system for head and neck squamous cell carcinoma: predicting treatment response and metastatic potential through multi-omics analysis
    XinYu Liu, Yujun Liu, Xutengyue Tian, Yue Xi, Miaomiao Lu, Xin Zou, Wantao Chen · 2025 · Discover Oncology
45. Specific oncogene activation of the cell of origin in mucosal melanoma
    Swathy Babu, Jiajia Chen, Chloé S. Baron, Kaiwen Sun, Emily J. Robitschek, Alicia M. McConnell, Constance Wu, Aikaterini Dedeilia, Moshe Sade-Feldman, Rodsy Modhurima et al. · 2025 · Nature Communications
46. A CD24+CD271+ melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance
    Olivia Knowles, Patricio Doldan, Isabella Hillier-Richardson, Sophia Lunetto, Stephanie Lunt, Gehad Youssef, Luke Gammon, Ian Campbell Mackenzie, Michael P. Philpott, Hasan Rizvi et al. · 2025 · BMC Biology
47. Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
    Sara M. Centuori, Carlos Caulı́n, Julie E. Bauman · 2021 · Current Treatment Options in Oncology
48. From single-omics to interactomics: How can ligand-induced perturbations modulate single-cell phenotypes?
    Luiz Felipe Piochi, A.T. Gaspar, Nícia Rosário‐Ferreira, António J. Preto, Irina Sousa Moreira · 2022 · Advances in protein chemistry and structural biology
49. Identification and validation of the cellular senescence-related molecular subtypes of triple negative breast cancer via integrating bulk and single-cell RNA sequencing data.
    Gaoda Ju, Kai Zeng, Linlin Lu, Han Diao, Hao Wang, Xiaomin Li, Tianhao Zhou · 2023 · PubMed Central
50. Functional genomics in cancer immunotherapy: computational approaches for biomarker and drug discovery
    Wee Loong Chin, Rachael M. Zemek, Willem Joost Lesterhuis, Timo Lassmann · 2019 · Molecular Systems Design & Engineering
51. Adaptive Immunity and the Tumor Microenvironment
    Han ., Lotze · 2020 · Cancer treatment and research
52. Cell state diversity promotes metastasis through heterotypic cluster formation in melanoma
    Nathaniel R. Campbell, Anjali N. Rao, Maomao Zhang, Maayan Baron, Silja Heilmann, Maxime Déforet, Colin Kenny, Lorenza P. Ferretti, Ting Hsiang Huang, Manik Garg et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
53. Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma
    David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Stefan Zimmermann, Rafael Durán et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
54. Dynamical modelling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
    Seemadri Subhadarshini, Sarthak Sahoo, Shibjyoti Debnath, Jason A. Somarelli, Mohit Kumar Jolly · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
55. CSPG4-targeting CAR-macrophages inhibit melanoma growth
    Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell, Elena Kurudza, R.L. Belote, Gianpietro Dotti, Robert L. Judson‐Torres, Melissa Quino Reeves, Samuel Henry Cheshier, Minna Roh‐Johnson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
56. Lactate Blocks Tertiary Lymphoid Structure Formation by Inhibiting B Cell Chemotaxis
    Victoire Boulat, Elena Alberts, Paul C. Driscoll, Miu Shing Hung, Ana Cunha, Jelmar Quist, Fangfang Liu, Carin Andrea Brundin, Ananya Bhalla, Lidia Avalle et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
57. The combination of single-cell and RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genes
    Sihan Luo, Daiyue Wang, Jiajie Chen, Shaocheng Hong, Yuanyuan Fang, Lu Cao, Yong Liang, Shengxiu Liu · 2024 · Journal of Cancer
58. Prognostic risk model of LIHC T-cells based on scRNA-seq and RNA-seq and the regulation of the tumor immune microenvironment
    Shoupeng Ding, Xiaomei Yi, Jinghua Gao, Chunxiao Huang, Shouzhao Zheng, Lixian Wu, Zihan Cai · 2024 · Discover Oncology
59. Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
    Andrew J. Kavran, Yulong Bai, Brian A. Rabe, Anna Kreshock, Andrew Fisher, Yelena Cheng, Anne C. Lewin, Chao Dai, Matthew J. Meyer, Konstantinos J. Mavrakis et al. · 2025 · Frontiers in Oncology
60. Multi-omics analysis and experiments uncover the link between cancer intrinsic drivers, stemness, and immunotherapy in ovarian cancer with validation in a pan-cancer census
    Yilin Li, Cen Chen, Xiaoyu Ji, Ningxiao Jiang, Fei Wang, Xiangqian Gao, Weiwei Chen, Qiang Tang, Li Yan, Shinan Zhang et al. · 2025 · Frontiers in Immunology
61. Comprehensive analysis of single-cell and bulk RNA sequencing data reveals an EGFR signature for predicting immunotherapy response and prognosis in pan-cancer
    Changchun Ye, Xiaoya Chen, Zilu Chen, Shiyuan Liu, Ranran Kong, Wenhao Lin, Minxia Zhu, Xuejun Sun, Zhengshui Xu · 2025 · Frontiers in Immunology
62. Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
    Jingrui Yan, Yu Zhang, Guohua Mao, Jun Yu, Tianxing Zhou, Jihui Hao · 2025 · MedComm – Oncology
63. Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
    Signe Caksa, Timothy J. Purwin, Dan A. Erkes, Kristen M. DeRosa, Erica L. Kitterman, Samantha M. Barnada, Casey D. Stefanski, Haley P. Wilson, Glenn L. Mersky, McKenna Q. Glasheen et al. · 2025 · Cancer Research
64. Tertiary Lymphoid Structures in Human Melanoma: Molecular Mechanisms and Therapeutic Opportunities
    Gelare Ghajar-Rahimi, Ishika Patel, Nabiha Yusuf · 2025 · Cells
65. CDK12 regulates cellular metabolism to promote glioblastoma growth
    Jeong-Yeon Mun, Chang Shu, Qiuqiang Gao, Zhe Zhu, Hasan Orhan Akman, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus David Siegelin · 2025 · JCI Insight
66. Unsupervised multiscale clustering of single-cell transcriptomes to identify hierarchical structures of cell subtypes
    Won‐Min Song, Ming Chen, Christian V. Forst, Bin Zhang · 2025 · GigaScience
67. Endothelial circadian rhythm genes as prognostic modulators of tumor progression and immune interactions: insights from pan-cancer single-cell RNA sequencing
    Hao Qin, Yong Wang, Yi-Fang Yan, Jie Liu, Yangyang Li, Yalan Xu · 2025 · International Journal of Surgery
68. A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma
    Yuntian Zhang, Marcus A. Urquijo, Rebecca G. Zitnay, Kayla Marks, R.L. Belote, Maike M. K. Hansen, Montana Ferita, Hannah M. Neuendorf, Tong Liu, Eric A. Smith et al. · 2025 · Cell Reports
69. scSurv: a deep generative model for single-cell survival analysis
    Chikara Mizukoshi, Yasuhiro Kojima, Shuto Hayashi, Ko Abe, Daisuke Kasugai, Teppei Shimamura · 2025 · Bioinformatics
70. Inhibition of GDF15/GFRAL: A novel opportunity for the treatment of solid tumors
    Pengyu Zhang, Yang Liu, Haoqiang Yang, Jinghui Li, Gexu Fan, Hengqi Bai, Xinfang Cao, Yanjun Li · 2025 · International Immunopharmacology
71. Revealing the Best Strategies for Rare Cell Type Detection in Multi-Sample Single-Cell Datasets
    Zhiwei Ye, Yinqiao Yan, Yuanyuan Yu, H. S. Wu · 2025 · Genes
72. Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes
    Lilly Anne Torland, J. Geisler, Y. Azimzade, A. Frafjord, Hogne Røed Nilsen, L. Buer, J. Lømo, Øystein Garred, A. Tahiri, M. Lyngra et al. · 2026 · Oncoimmunology
73. S-nitrosylation of IRF7 induced by NOS1 expression in melanoma suppresses anti-tumor immunity
    Yuxin Dai, Sisi Zeng, Keyi Li, Jinyan Huang, Minzhu Yang, Wenwen Gao, Xi Chen, Mengqiu Huang, Shuangyan Ye, Qianli Wang et al. · 2026 · Cell Death and Disease
74. Targeting Acod1/itaconate in cancer therapy: Mechanisms and opportunities
    Tianlin Deng, Xiuyan Li, Shuodong Wu, Jing Kong, Xiaodong Wu · 2026 · Pharmacological Research
75. The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti–PD-L1–Resistant Cancer
    Juliette Roels, Hamid Ghaedi, Jayaram Kancherla, Yiming Yang, Ramya Ganesan, Priyanka Babu, Katherine Williams, Xiaosai Yao, Rachana Pradhan, Xiangnan Guan et al. · 2026 · Cancer Research
76. Breaching the immune-cold barrier in pMMR/MSS metastatic colorectal cancer: emerging strategies beyond standard care
    Wenkai Kang, Zhiqiang Zhang, Wentao Li, Qingyuan Zhang, Ningning Li, Youheng Jiang, Junjing Zhang, Yulong He · 2026 · Frontiers in Immunology
77. MHC class I on target cells regulates CD4+ T cell-mediated immunity
    Emma Lauder, Mahnoor Naseer Gondal, Meng-Chih Wu, Akira Yamamoto, Laure Maneix, Dongchang Zhao, Yaping Sun, Marcin Cieslik, Arul M. Chinnaiyan, Pavan R. Reddy · 2026 · Nature Immunology
78. A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma
    Shiyou Wei, Yulan Deng, Jinho Lee, Hongbin Lan, Zhenyu Yang, Marilyne Labrie, Courtney B. Betts, Hao Duan, Benjamin J. Tate, Joanna Pucilowska et al. · 2026 · Cell Reports Medicine
79. High-content CRISPR activation screens identify synthetically lethal RNA-based mechanisms to sensitize cancer cells to targeted T cell cytotoxicity
    Reece Villarin Akana, Jeehyun Yoe, Olivia Laveroni, Chang Sun, Young-Min Kim, Livnat Jerby‐Arnon · 2026 · Nature Genetics
80. Moving Beyond Morphology to Multiplexed Molecular Imaging as the Next Frontier in Diagnostic Pathology
    Andréanne Gagné, Jia‐Ren Lin · 2026 · American Journal Of Pathology
81. Immu-Mela: An open resource for exploring immunotherapy-related multidimensional genomic profiles in melanoma
    Jing Yang, Shilin Zhao, Jing Wang, Quanhu Sheng, Qi Liu, Yu Shyr · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
82. Single-cell transcriptomic sequencing analysis of mechanistic insights into the IFN-γ signaling pathway in different tumor cells
    Lifang Zhou, Lu Xu, Guohong Qiao · 2024 · Clinical & Translational Oncology
83. Quantifying Personalized Shift-Work Molecular Portraits Underlying Alzheimer's Disease through Computational Biology
    Y. Xu, Guoqing Zhang, Li Yang, H. Qin, Zhuo Long Zhou, Qunlong Li, Huilin Liu, R. Wang, Z. Cai, L. Jing et al. · 2024 · The Journal of Prevention of Alzheimer s Disease
84. CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling
    Xinyi Huang, Baoqing Tian, Ziyuan Ren, Jingxin Zhang, Weiwei Yan, You Mo, Jupeng Yuan, Yujiao Ma, Ruiyang Wang, Rufei Liu et al. · 2024 · Therapeutic Advances in Medical Oncology
85. Myeloid-derived suppressor cells as important factors and potential targets for breast cancer progression
    Nan-Nan Du, Hua WAN, Hailing Guo, Xukuan Zhang, Xueqing Wu · 2024 · Journal of Zhejiang University (Medical Sciences)
86. CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sell hi Neutrophil‐Induced Stat5a + Progenitor Exhausted CD8 + T Cell
    Yu Zhang, Bao Sun, Rong Zhou, Zizhen Gong, Yong Han, Wenjie Tao, Chaoji Shi, Wuchang Zhang, Laikui Liu, Zhiyuan Zhang et al. · 2025 · Advanced Science
87. theRNA: a curated knowledgebase of functional RNA therapeutics spanning diverse modalities and disease applications
    Yifan Zhou, Yongfei Hu, Luowanyue Zhang, Tingting Wu, Suiyang Peng, Censhan Lin, Zhongxing Wang, Zhongguo Zhou, Jian Zheng, Jian Min Ren et al. · 2025 · Nucleic Acids Research
88. A six-miRNA signature as a novel biomarker for improving prediction of prognosis and patterns of immune infiltration in hepatocellular carcinoma.
    Zhitao Chen, Lele Zhang, Chenchen Ding, Kuiwu Ren, Dalong Wan, Shengzhang Lin · 2022 · PubMed Central
89. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction
    Yutian Sun, Ming Yang, Qingyuan Zhang · 2022 · Annals of Translational Medicine
90. Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy
    Xutong Gong, Rachel Karchin · 2023 · Scientific Reports
91. Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301
    Byungho Lim, Dabin Yoo, Younghwa Chun, Areum Go, Ji Yeon Kim, Ha Young Lee, Rebecca J. Boohaker, Kyungjin Cho, Sunjoo Ahn, Jin Soo Lee et al. · 2023 · Cancers
92. Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis
    Zuhui Pu, Qing Zhao, Jiaqun Chen, Yubin Xie, Lisha Mou, Xushan Zha · 2023 · Frontiers in Immunology
93. iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration
    Tolga Turan, Sarah Kongpachith, Kyle D. Halliwill, Robert T. McLaughlin, Mikhail Binnewies, Dhemath Reddy, Xi Zhao, Rebecca S. Mathew, Shiming Ye, Howard J. Jacob et al. · 2023 · Cancer Immunology Research
94. Single‐cell RNA sequencing of a poorly metastatic melanoma cell line and its subclones with high lung and brain metastasis potential reveals gene expression signature of metastasis with prognostic implication
    Yoon‐Seob Kim, Dokyeong Kim, Junseong Park, Yeun‐Jun Chung · 2023 · Experimental Dermatology
95. Clustering malignant cell states using universally variable genes
    Sang-Ho Yoon, Jin‐Wu Nam · 2023 · Briefings in Bioinformatics
96. A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
    Diana I. Albu, Benjamin J. Wolf, Yan Qin, Xianzhe Wang, Amy Daniel Ulumben, Mei Su, Vivian Li, Eirene Ding, Jose Angel Gonzalo, Jason Kong et al. · 2024 · OncoImmunology
97. Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma
    Yufeng Guo, Geyun Chang, Rui Wan, Xue Zhang, Zixiao Ma, Hua Bai, Jie Wang · 2024 · Journal of Cancer
98. Low‐Intensity Focused Ultrasound‐Responsive, Phase‐Change Nanodroplets to Remodel Macrophage Polarization and Enhance PD‐L1 Blockade Therapy
    Qin Zhang, Ci Yin, Junjie Liu, Hua Yang, Yanping Zhang, Qiaoxi Qin, Nianhong Wu, Rui Tang, Yuting Cao, Min Zheng et al. · 2025 · Small Structures
99. The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective
    Adan A. Rios, Georgina To’a Salazar, Ningyan Zhang, Zhiqiang An · 2019 · Antibody Therapeutics